Avi I. Einzig

2.1k citations
34 papers · 1.7k indexed · h-index 20

Impact in

  • Oncology top 2%
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Chemotherapy-related skin toxicity

Papers in

    • Cancer Treatment and Pharmacology 22
    • Colorectal Cancer Treatments and Studies 10
    • HER2/EGFR in Cancer Research 4
    • Lung Cancer Research Studies 3
    • Gastric Cancer Management and Outcomes 6
    • Lung Cancer Treatments and Mutations 4

Avi I. Einzig

34 papers receiving 1.6k citations

Peers

Avi I. Einzig
Comparison fields: 5 of 84
  • Oncology 1.2k
  • Dermatology 175
  • Reproductive Medicine 132
  • Pulmonary and Respiratory Medicine 411
  • Hematology 133
Replace David R. Gandara with:
David R. Gandara United States
Taher Al‐Tweigeri Saudi Arabia
R. Kath Germany
Christine M. Kearns United States
Peter Ang Singapore
Allyson J. Ocean United States
Elba A. Turbat‐Herrera United States
Yoshiyasu Nakamura Japan
Xiaoming Xing China
Haruhiko Makino Japan
Avi I. Einzig relative to David R. Gandara United States David R. Gandara's profile →
Citations per field
00.5×3.7×
David R. Gandara · 1×
Citations per year

Countries citing papers authored by Avi I. Einzig

Since Specialization
Citations

This map shows the geographic impact of Avi I. Einzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avi I. Einzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avi I. Einzig more than expected).

Fields of papers citing papers by Avi I. Einzig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avi I. Einzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avi I. Einzig. The network helps show where Avi I. Einzig may publish in the future.

Co-authors

The 25 scholars most cited alongside Avi I. Einzig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Avi I. Einzig Line = papers co-authored together Avi I. Einzig links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1989250
2 1987231
3 1992216
4 1996159
5 1991152
6 200475
7 199352
8 199750
9 199142
10 200042
11 199131
12 199530
13 199630
14
Taxol in malignant melanoma.
199328
15 199325
16 199625
17 199222
18 199621
19 199320
20 200219

About Avi I. Einzig

Avi I. Einzig is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Dermatology, Molecular Biology and Cell Biology, having authored 34 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (22 papers), Colorectal Cancer Treatments and Studies (10 papers), Chemotherapy-related skin toxicity (6 papers), Gastric Cancer Management and Outcomes (6 papers), HER2/EGFR in Cancer Research (4 papers), Microtubule and mitosis dynamics (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (1.2k citations), Dermatology (175 citations), Reproductive Medicine (132 citations), Pulmonary and Respiratory Medicine (411 citations) and Hematology (133 citations). Avi I. Einzig has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Peter H. Wiernik, Janice P. Dutcher, Richard B. Lipton, Gary L. Goldberg, Carolyn D. Runowicz, Edward L. Schwartz, J Strauman, Al B. Benson, Herbert H. Schaumburg and Stuart C. Apfel. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, Cancer, Medical Oncology and Cancer Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact